Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 18 10:38AM ET
26.31
Dollar change
+0.26
Percentage change
0.99
%
IndexS&P 500 P/E18.69 EPS (ttm)1.41 Insider Own0.04% Shs Outstand5.67B Perf Week1.22%
Market Cap149.09B Forward P/E8.65 EPS next Y3.04 Insider Trans0.80% Shs Float5.66B Perf Month3.05%
Income8.02B PEG- EPS next Q0.71 Inst Own67.16% Short Float1.68% Perf Quarter3.70%
Sales63.63B P/S2.34 EPS this Y-4.78% Inst Trans-0.46% Short Ratio2.35 Perf Half Y-10.12%
Book/sh15.56 P/B1.69 EPS next Y2.66% ROA3.65% Short Interest94.96M Perf Year-6.48%
Cash/sh3.61 P/C7.28 EPS next 5Y-0.88% ROE9.05% 52W Range24.48 - 31.54 Perf YTD-0.84%
Dividend Est.1.70 (6.46%) P/FCF15.16 EPS past 5Y-13.25% ROI5.42% 52W High-16.59% Beta0.63
Dividend TTM1.69 (6.42%) Quick Ratio0.92 Sales past 5Y17.19% Gross Margin66.76% 52W Low7.47% ATR (14)0.54
Dividend Ex-DateJan 24, 2025 Current Ratio1.17 EPS Y/Y TTM272.80% Oper. Margin26.92% RSI (14)52.70 Volatility2.02% 2.14%
Employees81000 Debt/Eq0.76 Sales Y/Y TTM8.77% Profit Margin12.60% Recom2.29 Target Price30.39
Option/ShortYes / Yes LT Debt/Eq0.68 EPS Q/Q112.15% Payout119.94% Rel Volume0.73 Prev Close26.05
Sales Surprise2.38% EPS Surprise33.59% Sales Q/Q24.66% EarningsFeb 04 BMO Avg Volume40.37M Price26.31
SMA200.53% SMA500.24% SMA200-4.90% Trades Volume6,397,188 Change0.99%
Date Action Analyst Rating Change Price Target Change
Dec-10-24Resumed BofA Securities Neutral $29
Nov-15-24Initiated Wolfe Research Underperform $25
Oct-25-24Resumed Citigroup Neutral $30
Oct-17-24Initiated Bernstein Mkt Perform $32
Aug-07-24Upgrade Daiwa Securities Neutral → Outperform
Mar-22-24Downgrade Argus Buy → Hold
Feb-23-24Initiated Guggenheim Buy $36
Jan-04-24Downgrade TD Cowen Outperform → Market Perform $32
Oct-20-23Resumed UBS Neutral $36 → $34
Oct-16-23Upgrade Jefferies Hold → Buy $38 → $39
Today 10:00AM
09:00AM
02:33AM
Mar-17-25 01:51PM
09:02AM
05:00AM Loading…
05:00AM
04:49AM
04:45AM
Mar-14-25 12:15PM
08:00AM
05:01AM
Mar-13-25 05:45PM
01:36PM
07:30AM
Mar-12-25 02:27PM
04:06PM Loading…
Mar-11-25 04:06PM
02:21PM
11:43AM
08:15AM
07:45AM
06:45AM
01:02AM
Mar-10-25 09:40AM
05:06AM
Mar-08-25 02:19PM
11:21AM
08:30AM
Mar-07-25 04:04PM
12:47PM
11:55AM
09:00AM Loading…
09:00AM
04:06AM
03:15AM
Mar-06-25 01:59PM
11:31AM
Mar-05-25 01:06PM
01:05PM
10:02AM
09:45AM
07:00AM
Mar-04-25 04:28PM
02:26PM
09:45AM
07:33AM
Mar-03-25 11:09PM
03:26PM
11:00AM
Mar-02-25 11:51AM
04:21AM
Mar-01-25 11:21AM
05:51AM
Feb-28-25 12:31PM
11:29AM
11:02AM
09:01AM
Feb-27-25 01:16PM
11:58AM
10:16AM
09:46AM
Feb-26-25 08:43AM
08:12AM
Feb-25-25 11:17AM
03:56AM
02:01AM
Feb-24-25 02:04PM
12:52PM
10:13AM
10:00AM
09:00AM
08:06AM
08:05AM
08:02AM
07:27AM
06:00AM
Feb-23-25 03:26PM
04:53AM
Feb-22-25 11:26PM
03:57AM
Feb-21-25 12:35PM
12:25PM
07:50AM
06:24AM
06:00AM
05:50AM
Feb-20-25 04:45AM
Feb-19-25 05:23PM
08:53AM
02:43AM
Feb-18-25 09:00PM
05:31PM
01:33PM
05:10AM
04:35AM
Feb-17-25 05:44AM
02:53AM
Feb-15-25 01:00PM
Feb-14-25 11:52AM
Feb-13-25 03:55PM
10:00AM
09:15AM
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMICO JENNIFER B.SVP & ControllerMar 04 '25Sale25.932,50064,82511,850Mar 06 01:57 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27 '25Option Exercise31.3122,416701,84531,063Mar 03 05:39 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27 '25Option Exercise31.3185,1822,667,048250,866Mar 03 05:38 PM
SAHNI PAYALExecutive Vice PresidentFeb 27 '25Option Exercise31.3119,054596,58144,242Mar 03 05:38 PM
McDermott MichaelExecutive Vice PresidentFeb 27 '25Option Exercise31.3148,4191,515,999122,413Mar 03 05:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27 '25Option Exercise31.31156,9144,912,977309,790Mar 03 05:37 PM
Fonseca LidiaExecutive Vice PresidentFeb 27 '25Option Exercise31.3172,6292,274,014111,534Mar 03 05:36 PM
BOURLA ALBERTChairman & CEOFeb 27 '25Option Exercise31.31582,82318,248,188931,744Mar 03 05:36 PM
McDermott MichaelExecutive Vice PresidentFeb 22 '25Option Exercise30.1711,125335,64187,636Feb 25 07:38 PM
DAMICO JENNIFER B.SVP & ControllerFeb 22 '25Option Exercise30.178,741263,71617,602Feb 25 07:38 PM
BOURLA ALBERTChairman & CEOFeb 22 '25Option Exercise30.17238,3997,192,498570,436Feb 25 07:06 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 22 '25Option Exercise30.1785,8242,589,310232,775Feb 25 07:05 PM
SAHNI PAYALExecutive Vice PresidentFeb 22 '25Option Exercise30.1712,714383,58137,099Feb 25 07:04 PM
SUSMAN SALLYExecutive Vice PresidentFeb 22 '25Option Exercise30.1763,5731,917,997225,184Feb 25 07:02 PM
BOSHOFF CHRISTOFFELPresident, R&DFeb 22 '25Option Exercise30.178,741263,716159,085Feb 25 06:58 PM
BLAYLOCK RONALD EDirectorFeb 13 '25Buy25.6519,457499,07227,707Feb 14 05:16 PM
Gottlieb ScottDirectorOct 30 '24Buy28.241,00028,24010,000Oct 31 04:06 PM
DAMICO JENNIFER B.SVP & ControllerAug 13 '24Sale28.665,154147,7148,582Aug 14 03:47 PM